Systemic fibrinolytic therapy using urokinase in central retinal artery occlusion - A case study;Systemische fibrinolytische therapie mit urokinase bei zentralarterienverschluss der netzhaut - Eine fallstudie

Deutsche Medizinische Wochenschrift

Volumn 130, Issue 16, 2005, Pages 1002-1006

  Von Mach, Marc A ^a   Guz A ^a   Wiechelt, J ^a   Pfeiffer, N ^a   Weilemann, L S ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

UROKINASE;

ADULT; AGED; ARTICLE; BLEEDING; CENTRAL RETINA ARTERY OCCLUSION; CLINICAL ARTICLE; CONSERVATIVE TREATMENT; CONTROLLED STUDY; CORONARY ARTERY; FEMALE; FIBRINOLYTIC THERAPY; GENETIC ANALYSIS; HUMAN; HYPERTENSION; MALE; PROGNOSIS; PULMONARY ARTERY; RISK FACTOR; SMOKING; STANDARDIZATION; SYMPTOMATOLOGY; SYSTEMIC DISEASE; THROMBOPHILIA; VISUAL ACUITY;

FEMALE; HEMORRHAGE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PLASMINOGEN ACTIVATORS; PROGNOSIS; RETINAL ARTERY OCCLUSION; RISK FACTORS; SMOKING; THROMBOLYTIC THERAPY; THROMBOPHILIA; URINARY PLASMINOGEN ACTIVATOR; VISUAL ACUITY;

EID: 17844397422     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-866777     Document Type: Article

References (29)

1. Augsburger JJ, Magargal LE. Visual prognosis following treatment of acute central retinal artery obstruction. Br J Ophthalmol 1980; 64: 913-917
2. Barth H, Stein H, Fasse A, Mehdorn HM. Intracerebral hemorrhage after systemic thrombolysis in patients with occlusion of the central retinal artery. Report of 2 cases Ophthalmologe 1996; 93: 739-744
3. Beatty S, Au Eong KG. Local intra-arterial fibrinolysis for acute occlusion of the central retinal artery: a meta-analysis of the published data. Br J Ophthalmol 2000; 84: 914-916
4. Bertram B, Wolf S, Fisches H, Schulte K, Hoberg A, Reim M. Thrombolytic treatment of retinal arterial occlusion with plasminogen activator. Klin Monatsbl Augenheilkd 1991; 198: 295-300
5. Breen LA. Atherosclerotic carotid disease and the eye. Neurol Clin 1991; 9: 131-145
6. Butz B, Strotzer M, Manke C, Roider J, Link J, Lenhart M. Selective intraarterial fibrinolysis of acute central retinal artery occlusion. Acta Radiol 2003; 44: 680-684
7. Cilveti Puche A, Lapeira Andraca M, Garcia Campos J. Fibrinolysis with rTPA in acute retinal arterial occlusion. Arch Soc Esp Oftalmol 2000; 75: 287-290
8. David NJ, Norton EWD, Gass JD, Beauchamp J. Fluorescein angiography in central retinal artery occlusion. Arch Ophthalmol 1977; 77: 619-629
9. Duker JS, Sivalingam A, Brown GC, Reber R. A prospective study of acute central retinal artery obstruction. The incidence of secondary ocular neovascularization. Arch Ophthalmol 1991; 47: 690-703
10. Framme C, Spiegel D, Roider J et al. Central retinal artery occlusion. Importance of selective intra-arterial fibrinolysis. Ophthalmologe 2001; 98: 725-730
11. Greiner K, Peetz D, Winkgen A et al. Genetic thrombophilia in patients with retinal vascular occlusion. Int Ophthalmol 1999; 23: 155-160
12. Habdous M, Herbeth B, Haddy N et al. Smoking, genetic polymorphisms of glutathione S-transferases and biological indices of inflammation and cellular adhesion in the STANISLAS study. EXCLI J 2004; 3: 58-67
13. Hayreh SS, Kolder HE, Weingeist TA. Central retinal artery occlusion and retinal tolerance time. Ophthalmology 1980; 87: 75-78
14. Hayreh SS. Retinal arterial occlusion with LIF using rTPA. Ophthalmology 1999; 106: 1236-1238
15. Kattah JC, Wang DZ, Reddy C. Intravenous recombinant tissue-type plasminogen activator thrombolysis in treatment of central retinal artery occlusion. Arch Ophthalmol 2002; 120: 1234-1236
16. Kleine G, Feinauer B. Acute cor pulmonale, a rare manifestation of carcinomatous lymphangiosis and hemangiosis. Dtsch Med Wochenschr 2002; 127: 2558-2560
17. Müller AJ, Neubauer AS, Schaller U, Kampik A European Assessment Group for Lysis in the Eye. Evaluation of minimally invasive therapies and rationale for a prospective randomized trial to evaluate selective intra-arterial lysis for clinically complete central retinal artery occlusion. Arch Ophthalmol 2003; 121: 1377-1381
18. Paques M, Vallee JN, Herbreteau D et al. Superselective ophthalmic artery fibrinolytic therapy for the treatment of central retinal vein occlusion. Br J Ophthalmol 2000; 84: 1387-1391
19. Rumelt S, Dorenboim Y, Rehany U. Aggressive systematic treatment for central retinal artery occlusion. Am J Ophthalmol 1999; 128: 733-738
20. Schmidt DP, Schulte-Monting J, Schumacher M. Prognosis of central retinal artery occlusion: local intraarterial fibrinolysis versus conservative treatment. Am J Neuroradiol 2002; 23: 1301-1307
21. Stone R, Zink H, Klingele T, Burde RM. Visual recovery after central retinal artery occlusion: two cases. Ann Ophthalmol 1977; 9: 445-450
22. Verstraete M. Use of thrombolytic drugs in non-coronary disorders. Drugs 1989; 38: 801-821
23. von Mach MA, Brinkmann C, Hansen T, Weilemann LS, Beyer J. Differences in pharmacokinetics and pharmacodynamics of insulin lispro and aspart in healthy volunteers. Exp Clin Endocrinol Diabetes 2002; 110: 416-419
24. von Mach MA, Schlosser J, Weiland M et al. Cryopreservation of islets of Langerhans: Optimization of protocols. EXCLI J 2003; 2: 6-21
25. Weber J, Remonda L, Mattle HP et al. Selective intra-arterial fibrinolysis of acute central retinal artery occlusion. Stroke 1998; 29: 2076-2079
26. Weill A, Cognard C, Piotin M et al. Persistent value of intra-arterial fibrinolysis 8 hours or more following central retinal artery occlusion or of its branches. J Fr Ophthalmol 1998; 21: 466-470
27. Weinberger AWA, Siekmann UPF, Wolf S et al RP>. Treatment of acute central retinal artery occlusion (CRAO) by hyperbaric oxygenation therapy (HBO) - pilot study with 21 patients. Klin Monatsbl Augenheilkd 2002; 219: 728-734
28. Zeymer U. Bolus fibrinolysis in acute myocardial infarction. Dtsch Med Wochenschr 2002; 127: 2083-2086
29. Zimmermann C, Braun B, Hust MH. Intrapericardial fibrinolysis as a therapeutic option in a case of purulent pericarditis. Dtsch Med Wochenschr 2003; 128: 2248-2250